定制基于循环德克斯的超分子纳米组件的树状结构,通过破坏内分泌网膜恒常性来增强瘤亡
Jiecheng Ji1, Jie Zhou1, Xue Li1
1Department of Radiology, Department of Pharmacy, Huaxi MR Research Center (HMRRC), Institution of Radiology and Medical Imaging, Institute of Breast Health Medicine, Precision Medicine Research Center, Frontiers Science Center for Disease-Related Molecular Network, Laboratory of Precision Cancer Therapeutics, and Laboratory of Stem Cell Biology, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China.
Acta biomaterialia
|February 11, 2025
概括
研究人员开发了用于癌症治疗的新型甲基化β-cyclopodextrin纳米剂. 增加甲基化β-cyclopodextrin (PMCD) 的比例增强了通过破坏内分泌网膜稳态和诱导无亡,一个非亡的细胞死亡,通过破坏内分泌网膜稳态提高了抗瘤功效.
科学领域:
- 生物材料科学 生物材料科学
- 纳米医学是一种纳米医学.
- 癌症治疗方法 癌症治疗方法
背景情况:
- 生物活性纳米材料在医学中广泛使用.
- 甲基化β-cyclopodextrin衍生的超分子生物活性纳米剂的临床应用尚未得到充分研究.
- 了解化学结构-生物性质关系对于优化纳米剂疗效至关重要.
研究的目的:
- 设计和制造超分子生物活性纳米组件,使用甲基β-环氧 (PMCD).
- 为了研究PMCD比例对树枝状侧链对抗瘤功效的影响.
- 为了阐明增强抗瘤活性的作用机制.
主要方法:
- 制造PMCD衍生的高分子生物活性纳米组件,具有不同的PMCD比例.
- 在实验室中评估纳米剂与内质网膜 (ER) 和诱导细胞死亡的相互作用.
- 在瘤模型中对抗瘤功效和副作用的体内评估.
主要成果:
- 具有较高PMCD比例的纳米组件表现出增强的抗瘤疗效.
- 具有最高PMCD比例的纳米剂P4有效地破坏了ER恒温,并诱导了瘤细胞亡.
- P4在体内表现出显著的抗瘤活性,副作用最小.
结论:
- 优化 PMCD 的比例在 dendronized 侧链是提高纳米剂抗瘤功效的关键.
- 从PMCD衍生出的纳米剂可以通过破坏ER恒温来诱导帕帕托斯.
- 这些发现支持开发基于PMCD的超分子生物活性剂用于瘤管理.
相关概念视频
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K


